Abstract

Introduction: Elevated blood lead level is associated with serious, often irreversible, health consequences. At present, the safe level of blood lead cannot be ascertained since the emerging data indicate the toxic potential to human organ system at a low level that was previously considered safe. Screening for blood lead level is not in regular practice in Nepal. This study is designed to evaluate the prevalence of detectable blood lead level in reproductive age group of Nepalese population that represents the wide local population. Materials and methods: 170 reproductive age group individual (20 to 49 years) attending Samyak diagnostic Pvt Ltd and Alka IVF and fertility centre for regular health checkup were included in this study for blood lead level analysis. The participants were categorized as normal or sub-fertile. Blood lead level was estimated using anodic stripping voltametry. Results: In total study participants, 28.8% of male and 25.8 % of female had BLL ≥3.0 µg/dL. The minimum detectable blood lead level in both male and female was 3.3 µg/dL while the maximum blood lead level was higher in male (15.5 µg/dL) than in female (8.4 µg/dL). The median blood lead level of the sample population was 3.7(4.8 -6.9) µg/dL. There was no significant difference in blood lead level between gender (p=0.108). Conclusion: It is justifiable to screen for blood lead level in the reproductive age group individual in Nepal.

Highlights

  • Lead is a toxic metal that adversely affects many physiologic functions through multiple biochemical mechanisms.[1]

  • The case definition for an elevated blood lead levels (BLL) is defined as ≥5 μg/dLby the Centers for Disease Control and Prevention (CDC) of the United States of America (US) no limit is safe.[2]

  • Whole blood collected in Ethylenediaminetetraacetic acid (EDTA) tube was used for the BLL analysis irrespective of the fasting state

Read more

Summary

Introduction

Lead is a toxic metal that adversely affects many physiologic functions through multiple biochemical mechanisms.[1]. The prevalence of high blood lead levels (BLL) in reproductive age group individuals is difficult to ascertain because of limited data. Even the BLL below 10 μg/dL is associated with deaths from cardiovascular diseases in the general population.[3] lead risk assessment is necessary as the previously recognized “safe” level of lead is being found to be associated with negative health outcomes. Elevated blood lead level is associated with serious, often irreversible, health consequences. The safe level of blood lead cannot be ascertained since the emerging data indicate the toxic potential to the human organ system at a low level that was previously considered safe. This study is designed to evaluate the prevalence of detectable blood lead levels in the reproductive age group of the Nepalese population that represents the wide local population

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call